|
|
|
|
FDG-PET for Vulvar Carcinoma Diagnosis
PET can play a useful diagnostic role for patients with vulvar carcinoma, researchers said at the Society of Gynecologic Oncologists (SGO) 41st Annual Meeting on Women's Cancer.PET using fluorodeoxyglucose (FDG) as a tracer (FDG-PET) is widely used in...
|
|
|
FDG-PET May Influence Management of Vulvar Carcinoma: Presented at SGO
-- Recent data suggest that positron emission tomography (PET) can play a useful diagnostic role for patients with vulvar carcinoma, researchers said here on March 15 at the Society of Gynecologic Oncologists (SGO) 41st Annual Meeting on Women's Cancer.PET...
|
|
|
Mundipharma International Limited: Levact(R) (bendamustine) Recommended for Approval in Europe for Treating Bl
/PRNewswire/ -- Mundipharma announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending that marketing authorisations can be granted in Germany and the...
|
|
|
Levact(R) (bendamustine) Recommended for Approval in Europe for Treating Blood Cancers
/PRNewswire/ -- Mundipharma announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending that marketing authorisations can be granted in Germany and the...
|
|
|
Levact(R) (bendamustine) Recommended for Approval in Europe for Treating Blood Cancers
/PRNewswire/ -- Mundipharma announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending that marketing authorisations can be granted in Germany and the...
|
|
|
Levact(R) (bendamustine) Recommended for Approval in Europe for Treating Blood Cancers
/PRNewswire/ -- Mundipharma announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending that marketing authorisations can be granted in Germany and the...
|
|
|
Levact(R) (bendamustine) Recommended for Approval in Europe for Treating Blood Cancers
/PRNewswire/ -- Mundipharma announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending that marketing authorisations can be granted in Germany and the...
|
|
|
Levact(R) (bendamustine) Recommended for Approval in Europe for Treating Blood Cancers
Mundipharma announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending that marketing authorisations can be granted in Germany and the following Member States...
|
|
|
CD150 regulates JNK1/2 activation in normal and Hodgkin's lymphoma B cells
Yurchenko MY et al.CD150 ligation inhibited cell proliferation of all studied HL cell lines and induced apoptosis in L1236 HL cells that did not depend on JNK activity. CD150 regulates JNK1/2 activation in normal and Hodgkin's lymphoma B cells.
|
|
|
Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit Against Cell Therapeutics, Inc
-Coughlin Stoia Geller Rudman & Robbins LLP (Coughlin Stoia) (http://www.csgrr.com/cases/cellthera/) today announced that a class action has been commenced in the United States District Court for the Western District of Washington on behalf of purchasers of...
|
|
|
Melanoma survivors at risk for other cancers
Melanoma survivors need to continue getting their lifelong exams.A new study that followed some 90,000 patients from 1973-2006 found melanoma survivors have a 28 percent increase risk of a second cancer. The most common second cancers (after melanoma) are...
|
|
|
Melanoma survivors at risk for other cancers
Melanoma survivors need to continue getting their lifelong exams.A new study that followed some 90,000 patients from 1973-2006 found melanoma survivors have a 28 percent increase risk of a second cancer. The most common second cancers (after melanoma) are...
|
|
|
Art Notes: concert for cancer treatment
Three local bands are taking the stage in Appomattox this weekend to raise money for resident Mary Gunter's treatment for Follicular Non-Hodgkin's Lymphoma.Set for 6 p.m. Saturday at the Black Rock Hunt Club, the concert will feature performances by...
|
|
|
Newarthill mum's cancer fear
A NEWARTHILL mother is concerned that contaminated land at Ravenscraig may have given her son cancer.John Paul Devlin, of Beechwood Drive, was diagnosed with Hodgkin's lymphoma three years ago at the age of 13. He now appears to have made a full...
|
|
|
Roche highlights 10 first- or best-in-class new drugs
Roche has been presenting its plans for future growth to the investment community in New York and says it expects to launch at least six new products by 2015.The Swiss giants late-stage pipeline comprises more than 35 additional indications for existing...
|
|
|
Brean Murray Initiates Coverage of Seattle Genetics (SGEN) with a Hold
Brean Murray initiates coverage of Seattle Genetics, Inc.(Nasdaq: SGEN) with a Hold rating. Brean analyst says, "We view Seattle Genetics as one of the strongest players in the monoclonal antibody field, with powerful technologies, a broad and promising...
|
|
|
Melanoma survivors at risk for other cancers
Melanoma survivors are at increased risk of other cancers as well as the return of their skin cancers, according to a new study, leading National Cancer Institute researchers to urge lifelong follow-up of such survivors.The study included data from more than...
|
|
|
Kendall Law Group Plans Class Action on Behalf of Cell Therapeutics, Inc. Shareholders
- Kendall Law Group announced today that it plans to join a lawsuit on behalf of shareholders of Cell Therapeutics, Inc.(NASDAQ:CTIC) alleging securities violations by Cell Therapeutics and certain of its officers for violations of the federal securities...
|
|
|
What to Expect for Biotech Stocks
Its not always easy being a biotech investor.The stocks are driven by very specific events that can make them shoot up 200% overnight or just as quickly lose all of their value. Marking these events on your calendar can help you plan for those times when...
|
|
|
Newarthill mum's cancer fear
A NEWARTHILL mother is concerned that contaminated land at Ravenscraig may have given her son cancer.John Paul Devlin, of Beechwood Drive, was diagnosed with Hodgkin's lymphoma three years ago at the age of 13. He now appears to have made a full...
|
|
|
LLS and Forma Collaborate on Lymphoma Drug
The Leukemia & Lymphoma Society (LLS) and Forma Therapeutics have entered into a collaboration to discover and develop small molecule compounds for the treatment of B cell lymphoma.The lymphoma target Bcl-6 is a transcriptional repressor that down...
|
|
|
The Leukemia & Lymphoma Society and FORMA Therapeutics Enter a Drug Discovery Alliance ...
The Leukemia & Lymphoma Society and FORMA Therapeutics announced they have begun a partnership to discover and develop small molecule compounds against a key lymphoma target, Bcl-6 WHITE PLAINS, NY, USA & CAMBRIDGE, MA, USA | March 15, 2010 | The...
|
|
|
Robbins Umeda LLP Announces Investigation of Cell Therapeutics, Inc.
SAN DIEGO-- (BUSINESS WIRE) -- has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by certain officers and directors of ("Cell Therapeutics" or the "Company") (NASDAQ: CTIC).Cell Therapeutics develops,...
|
|
|
Amlwch born Spartacus Actor in cancer battle
THE Anglesey-born star of US TV hit Spartacus: Blood and Sand has been diagnosed with cancer.Production on the controversial sword and sandals drama was halted after Amlwch actor Andy Whitfield was diagnosed with non-Hodgkin lymphoma. The 36-year-old...
|
|
|
Xencor, Inc. - Pharmaceuticals & Healthcare - Deals And Alliances Profile - New Report Published
Xencor, Inc.- Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary...
|
